EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
Status:
Completed
Trial end date:
2016-09-12
Target enrollment:
Participant gender:
Summary
The EARLY-MYO (EARLY routine catheterization after alteplase fibrinolysis vs. primary PCI in
acute ST-segment elevation MYOcardial infarction) is an investigator-initiated, prospective,
multicenter, randomized (1:1), open-label, actively-controlled, parallel group,
non-inferiority trial comparing the efficacy and safety of a PhI strategy with half-dose
fibrinolysis versus PPCI in STEMI patients presenting within 6 hours after symptom onset and
with an expected PCI-related delay of ≥60 min.